SETDB1 decline promotes the resistance to sorafenib via DRP1 phosphorylation-mediated mitochondrial dysfunction in HepG2 cells. Fan M, Wu J, Wu Y, Zhang Y, et al. Biochem Biophys Res Commun 2025;768:151934.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Fan M, Wu J, Wu Y, Zhang Y, et al. SETDB1 decline promotes the resistance to sorafenib via DRP1 phosphorylation-mediated mitochondrial dysfunction in HepG2 cells. Biochem Biophys Res Commun 2025;768:151934.
PMID: 40345011